Island Pharmaceuticals Limited (ASX:ILA)

Australia · Delayed Price · Currency is AUD

0.4700

+0.0050 (1.08%)

Aug 11, 2026, 3:49 PM AEST

Island Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	6.87	7.25	1.66	2	4.79	6.46
Cash & Short-Term Investments	6.87	7.25	1.66	2	4.79	6.46
Cash Growth	-5.27%	336.76%	-16.91%	-58.26%	-25.90%	646064300.00%
Other Receivables	-	0.18	0.89	0.02	0.02	0.06
Receivables	0.19	0.18	0.89	0.02	0.02	0.06
Prepaid Expenses	0.17	0.06	0.01	0.03	0.09	0.12
Total Current Assets	7.23	7.49	2.56	2.05	4.9	6.64
Total Assets	8.02	7.49	2.56	2.05	4.9	6.64

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accounts Payable	0.21	0.15	0.31	0.11	0.24	0.08
Accrued Expenses	0.65	0.18	0.3	0.15	0.34	0.14
Short-Term Debt	-	-	0.42	-	-	-
Other Current Liabilities	0	0	0.01	0	0	0.01
Total Current Liabilities	0.86	0.34	1.05	0.26	0.58	0.24
Total Liabilities	0.86	0.34	1.05	0.26	0.58	0.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Common Stock	34.12	31.63	22.39	19.9	19.9	19.83
Retained Earnings	-29.9	-25.08	-21.2	-19.76	-4.73	-2.13
Comprehensive Income & Other	2.94	0.61	0.33	1.65	-10.85	-11.3
Shareholders' Equity	7.16	7.16	1.52	1.79	4.32	6.4
Total Liabilities & Equity	8.02	7.49	2.56	2.05	4.9	6.64

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	-	-	0.42	-	-	-
Net Cash (Debt)	6.87	7.25	1.24	2	4.79	6.46
Net Cash Growth	-5.27%	485.58%	-38.03%	-58.26%	-25.90%	646064300.00%
Net Cash Per Share	0.03	0.04	0.01	0.02	0.06	0.35
Filing Date Shares Outstanding	269.05	247.24	126.77	81.27	81.27	80.97
Total Common Shares Outstanding	269.05	236.09	126.77	81.27	81.27	80.97
Working Capital	6.37	7.16	1.52	1.79	4.32	6.4
Book Value Per Share	0.03	0.03	0.01	0.02	0.05	0.08
Tangible Book Value	6.37	7.16	1.52	1.79	4.32	6.4
Tangible Book Value Per Share	0.02	0.03	0.01	0.02	0.05	0.08